190 related articles for article (PubMed ID: 36209236)
21. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
[TBL] [Abstract][Full Text] [Related]
22. Effects of Calcium Oxalate on Expression of Clusterin and Lower Urinary Tract Symptoms in Prostatitis and Benign Prostatic Hyperplasia Patients with Calculi.
Sun C; Xie G; Huang F; Liu X
Med Sci Monit; 2018 Dec; 24():9196-9203. PubMed ID: 30560838
[TBL] [Abstract][Full Text] [Related]
23. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
[TBL] [Abstract][Full Text] [Related]
24. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
[TBL] [Abstract][Full Text] [Related]
25. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
[TBL] [Abstract][Full Text] [Related]
26. Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.
Zumstein V; Betschart P; Vetterlein MW; Kluth LA; Hechelhammer L; Mordasini L; Engeler DS; Kessler TM; Schmid HP; Abt D
Eur Urol Focus; 2019 Nov; 5(6):1091-1100. PubMed ID: 30292422
[TBL] [Abstract][Full Text] [Related]
27. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.
Ficarra V; Rossanese M; Zazzara M; Giannarini G; Abbinante M; Bartoletti R; Mirone V; Scaglione F
Curr Urol Rep; 2014 Dec; 15(12):463. PubMed ID: 25312251
[TBL] [Abstract][Full Text] [Related]
28. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis.
Perera M; Roberts MJ; Doi SA; Bolton D
Eur Urol; 2015 Apr; 67(4):704-13. PubMed ID: 25466940
[TBL] [Abstract][Full Text] [Related]
29. The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study.
Li J; Li Y; Cao D; Huang Y; Peng L; Meng C; Wei Q
Aging Male; 2022 Dec; 25(1):88-93. PubMed ID: 35289705
[TBL] [Abstract][Full Text] [Related]
30. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
[TBL] [Abstract][Full Text] [Related]
31. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
[TBL] [Abstract][Full Text] [Related]
32. [Benign prostate hyperplasia with chronic prostatitis: an update].
Ma Y; Zhang WL
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
[TBL] [Abstract][Full Text] [Related]
33. [Effects of chronic bacterial prostatitis on changes in concentration and free and total prostatic specific antigen in the serum and urine from patients with benign prostatic hyperplasia and prostatic cancer].
Mazo EB; Grigor'ev ME; Stepenskiĭ AB
Urologiia; 2001; (5):3-7. PubMed ID: 11641977
[TBL] [Abstract][Full Text] [Related]
34. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.
Nickel JC
Curr Opin Urol; 2006 Jan; 16(1):5-10. PubMed ID: 16385194
[TBL] [Abstract][Full Text] [Related]
35. Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia.
Asare GA; Owusu-Boateng E; Asiedu B; Amoah BY; Essendoh E; Otoo RY
Andrologia; 2019 Sep; 51(8):e13321. PubMed ID: 31145504
[TBL] [Abstract][Full Text] [Related]
36. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
37. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
38. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi?
Kim SH; Jung KI; Koh JS; Min KO; Cho SY; Kim HW
Urol Int; 2013; 90(2):144-9. PubMed ID: 23295780
[TBL] [Abstract][Full Text] [Related]
39. [The microbiome in benign prostatic hyperplasia].
Magistro G; Füllhase C; Stief CG; Bschleipfer T
Urologe A; 2020 Oct; 59(10):1204-1207. PubMed ID: 32914231
[TBL] [Abstract][Full Text] [Related]
40. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
BJU Int; 2019 Jul; 124(1):27-34. PubMed ID: 30681264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
